All News

Worse asthma control and higher body mass index (BMI) are associated with lower exercise capacity in patients with severe asthma, especially female patients, according to a recent study.

A retrospective, single-center study found that obesity and family history were among several potential risk factors for pediatric obstructive sleep apnea (OSA).

Medication adherence is not the only area to focus on for older adults who have Medicare coverage. Optimizing treatment and medication access are also important.

A recent study examined whether an artificial intelligence (AI) trained risk model could screen for retinopathy of prematurity, a leading cause of preventable blindness in infants in low- and middle-income countries, via telehealth.

Anthony Fauci, MD says he will retire when President Joe Biden’s current term ends; the overturning of Roe v Wade has affected access to medicines outside of abortions; former FDA Commissioner Scott Gottlieb, MD, warns that the window for monkeypox containment may have closed.

A study in Blood Advances highlights the toll that a terminal diagnosis can have on everyone around a patient.

Over half of the patients (53%) included in the study indicated that frontal fibrosing alopecia had a negative impact on their health-related quality of life (HRQOL).

Participants in a digital acute musculoskeletal program experienced better pain and function outcomes compared with nonparticipants, demonstrating benefits for acute and subacute musculoskeletal conditions.

While prior authorizations are put in place to ensure appropriate use of expensive therapies, they create a substantial burden for clinicians and patients, said Sabin Dang, MD, ophthalmologist with The Retina Institute.

Polypharmacy and medication adherence are common problems among the Medicare patient population, and this article addresses how Medicare Advantage plans can address these challenges and improve patient outcomes.

Two posters presented at the American Society of Retina Specialists 40th Annual Scientific Meeting evaluated the impact of the COVID-19 pandemic on rates of patients lost to follow-up and patient perspectives regarding telehealth for retinal disease.

Patients with asthma hospitalized with COVID-19 in Michigan in 2020 had more severe outcomes after taking certain factors into account, according to a recent study.

Posters presented at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Meeting evaluated the association between long-term visual acuity outcomes and use of anti–vascular endothelial growth factor (VEGF) therapy, as well as patient and caregiver experience with ant-VEGF.

Elaine Goodman, MD, MBA, clinical lead for population health management at Mass General Brigham, talks about how the COVID-19 pandemic should impact developments in digital health management going forward.

While anti–vascular endothelial growth factor (VEGF) therapy is the first-line treatment for diabetic macular edema (DME), a majority of patients discontinue therapy after 6 months and there is no consensus on the ideal dosing paradigm.

Three methods of cosmetic surgery—local skin flap, full thickness skin graft, and secondary intention—were evaluated for their scarring risk following Mohs microscopic surgery on the distal third of the nose.

Many algorithms claiming to identify melanoma better than dermatologists are trained on retrospective datasets, which is not reflective of real-world clinical practice, said Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center.

A recent study found that teach-to-goal methods are more effective than brief interventions in metered-dose inhaler education for patients with chronic obstructive pulmonary disease (COPD) and asthma, but results may vary depending on levels of health literacy.

A machine learning model was able to predict visual outcomes and showed that the time from diagnosis to first treatment indicates visual improvement in patients with macular edema due to central retinal vein occlusion (CRVO).

Results looking at acceptance of minimal residual disease (MRD) status found that 60% of participants “would change at least one decision based on an MRD result,” and 54% would use both MRD status and disease risk to make decisions.

While comprehensive genetic profiling has the potential to change the course of certain patients’ cancers, a recent survey found that patients often have difficulty understanding results and their implications.

Most of the children readmitted to hospitals for asthma in Australia were preschool aged.

Frequent users of an app designed to support HIV pre-exposure prophylaxis (PrEP) adherence had higher adherence rates than individuals who used the app infrequently or not at all.

A new review notes advances and remaining questions, and calls for better incorporation of data from veterans.

The tool could help clinicians better screen patients for adjuvant chemotherapy following curative resection for intrahepatic cholangiocarcinoma (ICC).

Although technology is allowing for earlier detection of eye conditions, lack of reimbursement and insurance coverage remain major barriers to widespread use, explained speakers at the American Society of Retina Specialists 40th Annual Scientific Meeting.

A systematic review found that there was a bidirectional relationship between glaucoma and chronic kidney disease (CKD), especially in participants of East Asian descent.

A new review article outlines current agreements and disagreements between association guidelines, but notes the recommendations are likely to change more in the future.

Every year, the American Society of Retina Specialists releases the results of its latest Preferences and Trends Survey at the annual meeting. This year, the survey highlighted some surprising differences between US and international retina specialists, including off-label medication use and what drives drug choices for patients, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.

Faster and sectoral central location of ganglion cell complex thinning could be used to determine the risk of vision-related quality of life in patients with glaucoma.